awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38985503-0CBA3FFD-8650-4C24-BB70-FDDAED9687C2
Q38985503-0CBA3FFD-8650-4C24-BB70-FDDAED9687C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38985503-0CBA3FFD-8650-4C24-BB70-FDDAED9687C2
Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma.
P2860
Q38985503-0CBA3FFD-8650-4C24-BB70-FDDAED9687C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38985503-0CBA3FFD-8650-4C24-BB70-FDDAED9687C2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e7dc8ee408d3fed17a60607fc8b219ce7206788c
P2860
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer.